In Cardiovascular (Heart) and Non-Cardiovascular Diseases, the most common, complex conditions targeted for interventional procedures include:
•Atrial Fibrillation (AF)-Over 5 millionin US alone, growing to 12 million by 2030
•Pacing/Heart Failure: Pacing of the left lower chamber of the heart -Left Bundle Pacing-Over1million patients could benefit
•Stroke: Non-surgical placement of Left Atrial Appendage devices to prevent stroke and heart disease (SHD)
•Nonsurgical placement of Valves
Almost all these therapies involve some form of 2D X-ray imaging either alone or in combination with other mapping tools. Unfortunately, it is difficult to target appropriate therapy sites using 2D imaging only.
APN provides a 3D cardiac mapping system that allows physicians to perform interventional procedures, critical for the treatment of AF and other heart rhythm disorders.
Value Proposition: Converts 2D X-Ray Fluoro into 3D images
Market: Over 1 million procedures in the US that could benefit from this technology
Key Benefits: 1.) Less Fluoro Time 2.) Improved Efficacy 3.) Lower Cost & Higher Reimbursement
Current Activity:
•Five Systems are already placed in the market today with over 800 procedures completed.
•Technology Integration Partnership established with GE Healthcare Partnerships and discussions at various levels with: Boston Scientific, Medtronic, Nvidia and others
•5 LOIs received for systems in India
•One system was recently placed in Fortis (20 hospital system in India)
•Partnership with China MedTech company - ongoing
•UCLA , Grafton hospital next launches in US
•Government of Kerala (India) – Ongoing discussion for investment
Several publications and presentations have been made, over 19 patents are issued
Ready to Ask For Funding for your company?
Post a Funding Request